These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1643634)

  • 21. Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.
    Lau DH; Durán GE; Sikic BI
    J Natl Cancer Inst; 1992 Oct; 84(20):1587-92. PubMed ID: 1404452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lidamycin metabolism in vitro].
    Wen YQ; Meng ZY; Chen SZ; Zhu XX; Dou GF
    Yao Xue Xue Bao; 2011 Sep; 46(9):1132-6. PubMed ID: 22121787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes.
    Quintieri L; Geroni C; Fantin M; Battaglia R; Rosato A; Speed W; Zanovello P; Floreani M
    Clin Cancer Res; 2005 Feb; 11(4):1608-17. PubMed ID: 15746066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel enzyme-prodrug combinations for use in cytochrome P450-based gene therapy for cancer.
    Baldwin A; Huang Z; Jounaidi Y; Waxman DJ
    Arch Biochem Biophys; 2003 Jan; 409(1):197-206. PubMed ID: 12464259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of methoxymorpholino-doxorubicin in rat, dog and monkey liver microsomes: comparison with human microsomes.
    Beulz-Riche D; Robert J; Menard C; Ratanasavanh D
    Fundam Clin Pharmacol; 2001 Dec; 15(6):373-8. PubMed ID: 11860524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes.
    Beulz-Riché D; Robert J; Riché C; Ratanasavanh D
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):274-80. PubMed ID: 11914905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
    Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
    Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.
    Lau DH; Duran GE; Lewis AD; Sikic BI
    Br J Cancer; 1994 Jul; 70(1):79-84. PubMed ID: 8018545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldrin epoxidation in flathead mullet (Mugil cephalus): possible involvement of CYP1A and CYP3A.
    Bozcaarmutlu A; Turna S; Sapmaz C; Arinc E; Yenisoy-Karakaş S
    J Biochem Mol Toxicol; 2014 Jun; 28(6):271-80. PubMed ID: 24756956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of granisetron on in vitro metabolism of doxorubicin, irinotecan and etoposide.
    Watanabe Y; Nakai H; Hoshiai H
    Curr Med Res Opin; 2005 Mar; 21(3):363-8. PubMed ID: 15811204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.
    Kronbach T; Fischer V; Meyer UA
    Clin Pharmacol Ther; 1988 Jun; 43(6):630-5. PubMed ID: 3378384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin metabolism in human liver microsomes and its inhibition by other drugs.
    Henricsson S; Lindholm A; Aravoglou M
    Pharmacol Toxicol; 1990 Jan; 66(1):49-52. PubMed ID: 2308907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe metabolic impairment with increasing age for CYP3A and CYP2D substrates in rats: Possible consequences for drug development.
    Srinivas NR
    Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28593732
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytochrome P-450 expression in sudden infant death syndrome.
    Treluyer JM; Cheron G; Sonnier M; Cresteil T
    Biochem Pharmacol; 1996 Aug; 52(3):497-504. PubMed ID: 8687505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for covalent binding of adriamycin to rat liver microsomal proteins.
    Ghezzi P; Donelli MG; Pantarotto C; Facchinetti T; Garattini S
    Biochem Pharmacol; 1981 Jan; 30(2):175-7. PubMed ID: 7236308
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation of pesticide toxicity in birds: role of cytochrome P-450.
    Walker CH; Johnston GO
    Biochem Soc Trans; 1993 Nov; 21(4):1066-8. PubMed ID: 8131899
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel Doxorubicin prodrug with controllable photolysis activation for cancer chemotherapy.
    Ibsen S; Zahavy E; Wrasdilo W; Berns M; Chan M; Esener S
    Pharm Res; 2010 Sep; 27(9):1848-60. PubMed ID: 20596761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
    Yang JJ; Cheng C; Yang W; Pei D; Cao X; Fan Y; Pounds SB; Neale G; Treviño LR; French D; Campana D; Downing JR; Evans WE; Pui CH; Devidas M; Bowman WP; Camitta BM; Willman CL; Davies SM; Borowitz MJ; Carroll WL; Hunger SP; Relling MV
    JAMA; 2009 Jan; 301(4):393-403. PubMed ID: 19176441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.
    Lu H; Chen CS; Waxman DJ
    Cancer Gene Ther; 2009 May; 16(5):393-404. PubMed ID: 19011599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.
    Chin DL; Lum BL; Sikic BI
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):259-69. PubMed ID: 12361740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.